Collectively, the data obtained from the biopsies of patients with FSGS show that GPR126 expression is also increased upon disease in humans, yet the changes are localized to a subpopulation of PECs, namely PECs belonging to glomerular FSGS lesions. The gene discussed is ADGRG6; the disease is focal segmental glomerulosclerosis.